☆ 4.4 Meeting Abstract

BUROSUMAB, A FULLY HUMAN ANTI-FGF23 MONOCLONAL ANTIBODY, FOR X-LINKED HYPOPHOSPHATEMIA (XLH): RESULTS FROM TWO PHASE 2 TRIALS IN AFFECTED CHILDREN 1-12 YEARS OLD

PEDIATRIC NEPHROLOGY (2018)

Add to Collection

Journal

PEDIATRIC NEPHROLOGY
Volume 33, Issue 10, Pages 1819-1819

Publisher

SPRINGER

Keywords

-

Categories

Pediatrics Urology & Nephrology

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.